Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:1438-1444

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fulton, J. E.
Right arrow Articles by Shekelle, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fulton, J. E.
Right arrow Articles by Shekelle, R. B.

(Circulation. 1997;96:1438-1444.)
© 1997 American Heart Association, Inc.


Articles

Cigarette Smoking, Weight Gain, and Coronary Mortality

Results From the Chicago Western Electric Study

Janet E. Fulton, PhD; ; Richard B. Shekelle, PhD

From The University of Texas–Houston, Health Science Center, School of Public Health.

Correspondence to Janet E. Fulton, PhD, Centers for Disease Control and Prevention, Division of Nutrition and Physical Activity, 4770 Buford Highway Northeast, Mailstop K46, Atlanta, GA 30341-3724.

Background Prospective studies of overweight and coronary heart disease (CHD) have presented inconsistent findings. Previous inconsistencies may be explained by the modifying effect of cigarette smoking on the association between weight gain and coronary mortality.

Methods and Results We prospectively studied 1531 men 40 to 59 years of age who were employed at the Hawthorne Works of the Western Electric Company in Chicago, Ill. Information collected at the initial examination in 1958 included recalled weight at age 20, present weight, height, smoking status, and other CHD risk factors. Vital status was known for all men on the 25th anniversary: 257 CHD deaths occurred over 31 644 person-years of experience. Cox regression analysis was used to investigate risk of coronary mortality associated with change in body mass index ({Delta}BMI) and its modification by smoking status after adjustment for age, major organ system disease, family history of CHD, and BMI at age 20. Adjustment was not performed for blood pressure or serum total cholesterol because these are intervening variables. {Delta}BMI was positively associated with risk of coronary mortality in never-smokers but not in current-smokers (P for interaction=.088). For never-smokers with {Delta}BMI classified as stable, low gain, moderate gain, or high gain, adjusted relative risks of coronary mortality were 1.00, 1.75, 1.75, and 3.07, respectively (P for trend=.010). For current-smokers, the respective adjusted relative risks were 1.00, 0.78, 1.05, and 1.03 (P for trend=.344).

Conclusions These results support the hypothesis that cigarette smoking modifies the association between weight gain and coronary mortality. Future investigations of weight gain and coronary mortality should account for the modifying effect of cigarette smoking.


Key Words: obesity • epidemiology • cardiovascular diseases • exercise




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
M. M. Yore, J. E. Fulton, D. E. Nelson, and H. W. Kohl III
Cigarette Smoking Status and the Association between Media Use and Overweight and Obesity
Am. J. Epidemiol., October 1, 2007; 166(7): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. E. Widlansky, H. D. Sesso, K. M. Rexrode, J. E. Manson, and J. M. Gaziano
Body Mass Index and Total and Cardiovascular Mortality in Men With a History of Cardiovascular Disease
Arch Intern Med, November 22, 2004; 164(21): 2326 - 2332.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F.-J. Neumann, W. Hochholzer, G. Pogatsa-Murray, A. Schomig, and M. Gawaz
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1323 - 1328.
[Abstract] [Full Text] [PDF]